Acute coronary syndrome in cancer patients. Part I: pathophysiology, clinical presentation and diagnosis Acute coronary syndrome in cancer patients. Part I: pathophysiology, clinical presentation and diagnosis

Grzegorz Piotrowski

OncoReview 2020; 2(38): 41-47. DOI: 10.24292/01.OR.220300620.1

Pixantrone – anticancer drug in the monotherapy of aggressive lymphomas Pixantrone – anticancer drug in the monotherapy of aggressive lymphomas

Janusz Hałka

OncoReview 2020; 2(38): 48-51. DOI: 10.24292/01.OR.220300620.2

Partial remission in patient with Richter syndrome: an „emergency” treatment with pixantrone Partial remission in patient with Richter syndrome: an „emergency” treatment with pixantrone

Paweł Szwedyk

OncoReview 2020; 2(38): 52-56. DOI: 10.24292/01.OR.220300620.3

Application of pixantrone in a III line of treatment as a bridge therapy to allotransplantation of stem cells Application of pixantrone in a III line of treatment as a bridge therapy to allotransplantation of stem cells

Anna Kwiatkowska-Pamuła, Aleksandra Janeczek, Sebastian Giebel

OncoReview 2020; 2(38): 57-61. DOI: 10.24292/01.OR.220300620.4

Complete response to pixantrone as a salvage therapy in a relapsed/refractory diffuse large B-cell lymphoma Complete response to pixantrone as a salvage therapy in a relapsed/refractory diffuse large B-cell lymphoma

Anna Pasternak

OncoReview 2020; 2(38): 62-68. DOI:10.24292/01.OR.220300620.5

Spektakularna skuteczność chemioterapii neoadiuwantowej u pacjentki z rozpoznaniem raka szyjki macicy w stopniu IB2 według FIGO 2009 r. Spectacular efficacy of neoadjuvant chemotherapy in a patient with cervical cancer of IB2 grade according to FIGO 2009

Kamila Kaźmierczak, Błażej Nowakowski, Joanna Kufel-Grabowska, Witold Cholewiński

OncoReview 2020; 2(38): 69-76. DOI: 10.24292/01.OR.220300620.6

ELF3 as an important factor in carcinogenesis – a brief review of the recent studies ELF3 as an important factor in carcinogenesis – a brief review of the recent studies

Julia Domańska, Kamil Poboży, Michał Kuryłek, Marta M. Fudalej, Aleksandra Sobiborowicz, Andrzej Deptała, Anna M. Badowska-Kozakiewicz

OncoReview 2020; 2(38): 77-81 DOI: 10.24292/01.OR.220290520.